These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2362794)

  • 1. [Clinical results of conventional fractionation radiotherapy for glottic and supraglottic laryngeal cancers--the usefulness of hyperfractionation for these cancers].
    Masunaga S; Ono K; Tsutsui K; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):139-45. PubMed ID: 2362794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
    Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
    Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitive radiation therapy for moderately advanced laryngeal cancer: effects of accelerated hyperfractionation.
    Okubo M; Nishimura Y; Shibata T; Nakamatsu K; Kanamori S; Tachibana I; Koike R; Nishikawa T; Mori K
    Jpn J Clin Oncol; 2010 Oct; 40(10):944-8. PubMed ID: 20534687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical radiotherapy for T3 laryngeal cancers.
    Uno T; Itami J; Kotaka K; Toriyama M
    Strahlenther Onkol; 1996 Aug; 172(8):422-6. PubMed ID: 8765344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis.
    Yücetürk AV; Celik O; Eskiizmir G
    Kulak Burun Bogaz Ihtis Derg; 2003 Nov; 11(5):129-33. PubMed ID: 15542939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative estimation of cure rates for supraglottic and glottic cancer in radiotherapy.
    Goleń M; Składowski K; Maciejewski B
    Neoplasma; 1999; 46(1):66-71. PubMed ID: 10355537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early stages of laryngeal cancer (I-II stage) and therapeutic options: case report and review of literature].
    Margarino G; Schenone G; Scala M; Mereu P; Comandini D; Corvo R; Scolaro T; Badellino F
    Acta Otorhinolaryngol Ital; 1996 Feb; 16(1):40-6. PubMed ID: 8984839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy for T1 and T2 laryngeal cancer: the Dalhousie University experience.
    Hafidh M; Tibbo J; Trites J; Corsten G; Hart RD; Nasser J; Wilke D; Mark Taylor S
    J Otolaryngol Head Neck Surg; 2009 Aug; 38(4):434-9. PubMed ID: 19755083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years.
    Tamura Y; Tanaka S; Asato R; Hirano S; Yamashita M; Tamaki H; Ito J
    Acta Otolaryngol Suppl; 2007 Feb; (557):62-5. PubMed ID: 17453448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial laryngectomy after irradiation failure.
    Yiotakis J; Stavroulaki P; Nikolopoulos T; Manolopoulos L; Kandiloros D; Ferekidis E; Adamopoulos G
    Otolaryngol Head Neck Surg; 2003 Feb; 128(2):200-9. PubMed ID: 12601315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
    Jones AS; Fish B; Fenton JE; Husband DJ
    Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results.
    Wang CC; Nakfoor BM; Spiro IJ; Martins P
    Cancer J Sci Am; 1997; 3(2):88-91. PubMed ID: 9099458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy of laryngeal cancer. General principles and results in T1 and T2 cases.
    De Schryver A
    Acta Otorhinolaryngol Belg; 1992; 46(2):187-95. PubMed ID: 1605021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour volume: implications in T2/T3 glottic/supraglottic squamous cell carcinoma.
    Lo SM; Venkatesan V; Matthews TW; Rogers J
    J Otolaryngol; 1998 Oct; 27(5):247-51. PubMed ID: 9800621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiation treatment of early stage supraglottic cancer].
    Spriano G; Ferrario F; Roselli R; Piantanida R; Antognoni P
    Ann Otolaryngol Chir Cervicofac; 1999 May; 116(2):66-70. PubMed ID: 10378034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
    Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
    Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiotherapy of laryngeal carcinoma (T1a/b excluding glottic cancer). Critical review of the literature and personal experience].
    Gabriele P; Orecchia R
    Radiol Med; 1991 Mar; 81(3):320-6. PubMed ID: 2014340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy in early glottic carcinoma: significance of prognostic factors and dose fractionation.
    Dinshaw KA; Sharma V
    Indian J Cancer; 1990 Sep; 27(3):143-53. PubMed ID: 2090566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Exclusive radical radiotherapy of laryngeal tumors: 10-year experience].
    Basilico L; Taraborrelli M; Laudadio L; Nuzzo A; Basilico NF; Peretti G; D'Alessandro M; Neri G; Croce A
    Radiol Med; 1997; 94(1-2):90-3. PubMed ID: 9424659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.